Warning Issued Over Mounjaro Weight Loss Medications

Strategic Insights -

As the UK's obesity crisis deepens, experts are sounding the alarm over a "common mistake" in prescribing Mounjaro, a slimming injection available on the NHS. A nurse has warned that thousands of patients could be at risk of life-threatening organ failure due to a lack of mandatory blood screening. The Medicines and Healthcare products Regulatory Agency (MHRA) is investigating reports of pancreatitis linked to GLP-1 drugs like Mounjaro, Ozempic, and Wegovy, with over 560 reports and 10 deaths. Meanwhile, genetic screening is being explored as a way to make prescribing safer in the future.

Key Takeaways:

  • A nurse has warned that thousands of patients taking Mounjaro may be at risk of life-threatening organ failure due to a lack of mandatory blood screening.
  • Experts believe high fat levels, combined with dehydration and other factors, could make certain people more vulnerable to pancreatitis, a condition that can trigger organ failure and even prove fatal in severe cases.
  • People with uncontrolled diabetes are also at greater risk of becoming severely dehydrated, which can be very serious.
  • Adverse drug reactions already cost the NHS an estimated £2.2 billion a year in hospital stays alone, and account for one in six hospital admissions.
  • Genetic testing could prevent almost a third of side effects to medicines.
  • Mounjaro has been linked to side effects such as nausea, diarrhoea, and dehydration, which can lead to headaches, dizziness, and, in rare cases, seizures or kidney failure if untreated.
  • Around 1.5 million people in the UK are thought to be using weight loss jabs, with many paying privately as NHS supplies remain limited.
  • The main warning sign of pancreatitis is severe stomach pain radiating to the back that doesn't go away, and anyone experiencing this is urged to seek urgent medical attention.

Statistics:

  • Over 560 reports of pancreatitis linked to GLP-1 drugs have been reported to the MHRA since their launch.
  • 10 deaths have been linked to pancreatitis caused by GLP-1 drugs.
  • Almost a third of side effects to medicines could be prevented with genetic testing.
  • Adverse drug reactions already cost the NHS an estimated £2.2 billion a year in hospital stays alone.
  • 1.5 million people in the UK are thought to be using weight loss jabs.

Sources:

  • Mail Online
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • Genomics England
  • Bloomberg via Getty Images
  • Reuters